Cancer vaccine THERATOPE® - Biomira

Drugs in R and D

Volumn 4, Issue 4, 2003, Pages 236-240

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; AROMATASE INHIBITOR; CANCER VACCINE; CYCLOPHOSPHAMIDE; FLUOROURACIL; FOLINIC ACID; FULVESTRANT; GLYCOPROTEIN; MUCIN; RALTITREXED; THERATOPE;

BREAST CANCER; CANCER GROWTH; CANCER SURVIVAL; CLINICAL TRIAL; COLON CANCER; DRUG INDUSTRY; DRUG MARKETING; DRUG SAFETY; DRUG TOLERABILITY; DYSPNEA; FEMALE; FLU LIKE SYNDROME; HUMAN; HYPOXIA; IMMUNE RESPONSE; IMMUNOSTIMULATION; OVARY CANCER; PATENT; PRIORITY JOURNAL; REVIEW; STATISTICAL SIGNIFICANCE; STEM CELL TRANSPLANTATION;

EID: 0042628157     PISSN: 11745886     EISSN: None     Source Type: Journal    
DOI: 10.2165/00126839-200304040-00004     Document Type: Review

References (8)

1. Biomira Inc. FDA grants fast track status for THERATOPE (R) vaccine. Media Release: [1 page], 8 May 2000. Available from URL: http://www.biomira.com
2. Biomira Inc. Restuls of THERATOPE (R) vaccine in colorectal cancer patients may indicate a survival benefit for patients who have failed first-line chemotherapy. Media Release: [2 pages], 14 May 2001. Available from URL: http://www.biomira.com
3. Freedman RS, Kudelka AP, Verschraegen CF, et al. Therapeutic anti-cancer vaccine: a randomized double blind dose comparison study of sialyl TN-KLN Hith Detox-B SE adjuvant for active specific immunotherapy of ovarian cancer. 34th Annual Meeting of the American Society of Clinical Oncology 17: 365, 16 May 1998
4. Sandmaier BM, Oparin DV, Holmberg LA. Evidence of a cellular immune response against sialyl-Tn breast and ovarian cancer patients after high-dose chemotherapy, stem cell rescue, and immunization with theratope STn-KLH cancer vaccine. Journal of Immunotherapy 22: 54-66, Jan 1999
5. Biomira Inc. Fred Hutchinson Cancer Research Center investigator presents new data on optimal Theratope (R) vaccine formulation at international symposium. Media Release: [2 pages], 29 Mar 2001. Available from URL: http://www.biomira.com
6. Holmberg LA, Oparin DV, Gooley T, et al. Clinical outcome of breast and ovarian cancer patients treated with high-dose chemotherapy, autologous stem cell rescue and THERATOPE (Rm) STn-KLH cancer vaccine. Bone Marrow Transplantation 25: 1233-1241, No. 12, Jun 2000
7. MacLean GD, Miles DW, Rubens RD, et al. Enhancing the effect of THERATOPE STn-KLH cancer vaccine in patients with metastatic breast cancer by pretreatment with low-dose intravenous cyclophosphamide. Journal of Immunotherapy [with Emphasis on Tumor Immunology] 19: 309-316, Jul 1996
8. Cunningham D, Zalcberg JR, Rath U, et al. Final results of a randomised trial comparing Tomudex (Rm) (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer. Annals of Oncology 7: 961-965, Nov 1996